Outcomes
SECONDARY
The primary outcome was change in median daily step count. This was assessed via ActiGraph GT3X accelerometers worn on the right hip for seven days at baseline (T1) and immediately post-intervention (week 17/18; T2; primary endpoint). Median daily step count (steps/day) was then derived using ActiLife v6.13.3 analysis software (ActiGraph, Pensacola, FL, USA).The secondary outcomes of change in self-reported transport-related physical activity and total physical activity (minutes/week and MET-minutes/week) were assessed at baseline and post-intervention via the International Physical Activity Questionnaire -long version (IPAQ-L) [Tertiary outcomes of change in self-reported leisure-time physical activity (minutes/week and MET-minutes/week) and sedentary time (min/day) were assessed via IPAQ-L. An objective assessment of sedentary time (min/day) was also determined using ActiGraph GT3X accelerometers.